Medical device company Dermalux has launched the Dermalux Tri-Wave MD.
The company shares that the new medical device features clinically proven LED phototherapy, offering a non-invasive, drug-free alternative to antibiotics and isotretinoin.
Using the three most validated wavelengths, blue (415 nm), red (633 nm) and near infrared (830 nm), Dermalux Tri-Wave MD targets acne at multiple levels. The blue light eliminates acne-causing bacteria, the red light stimulates collagen and calms inflammation, while near infrared supports wound healing and reduces scarring. The system treats both facial and body acne efficiently, delivering up to 240 j/cm² in a single session.
Consultant dermatologist Dr Justine Hextall, who worked on the protocol with a medical advisory board , explains, “LED phototherapy works synergistically with topical treatments to reduce inflammation, repair the skin barrier, and control acne without compromising the gut microbiome or causing systemic side effects.” Dr Hextall has reported significant improvements within two to four weeks for both teen and adult acne patients, with maintenance sessions sustaining long-term skin health. By addressing hormonal and inflammatory triggers holistically, Dermalux Tri-Wave MD phototherapy offers practitioners a safe, versatile and clinically validated alternative which reduces the need for antibiotics while promoting overall skin resilience.
This content was written and sponsored by Dermalux